Recordati

Equities

Market Closed - Borsa Italiana Other stock markets 11:45:00 2026-02-13 am EST			5-day change	1st Jan Change
47.90 ^EUR	+1.05%		+1.48%	-1.32%

Feb. 13	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE
Feb. 13	DIARY - Italy to March 31	RE

Published on 11/12/2025 at 10:20 am EST - Modified on 11/12/2025 at 02:36 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Recordati 9 Months 2025 Results Conference Call.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Feb. 13	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE
Feb. 13	DIARY - Italy to March 31	RE
Feb. 12	Barclays Upgrades Recordati to Equalweight Rating	MT
Feb. 12	Italy - Factors to watch on February 12	RE
Feb. 11	TIM and Italgas Push Higher, but the Mib Remains Bearish	AN
Feb. 10	Recordati Purchases Own Shares Worth Approximately EUR 3 Million	AN
Feb. 10	DIARY - Italy to March 31	RE
Feb. 03	Recordati Buys Back Over EUR3 Million in Own Shares	AN
Feb. 03	Italy - Factors to watch on February 3	RE
Feb. 02	Europe Expected to Open Lower, Gold Slide Continues	AN
Jan. 30	Mib Outperforms Europe Ahead of S&P, Campari Leads Gains	AN
Jan. 30	Markets Rise Amid Strong Euro and Earnings Season	AN
Jan. 30	Recordati and Moderna Sign Global Agreement on mRNA Therapy for Rare Disease	AN
Jan. 29	Moderna Collaborates With Recordati to Advance, Commercialize Investigational Therapy to Treat Metabolic Disorder	MT
Jan. 29	Recordati announces collaboration with Moderna for mRNA-3927	RE